<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Results of the study of special characteristics of the course of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>) in women with periportal <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (PCMP) are presented </plain></SENT>
<SENT sid="1" pm="."><plain>We have found that prevalence of PCMP in the structure of <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> is 9.5% </plain></SENT>
<SENT sid="2" pm="."><plain>PCMP compared with idiopathic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> is characterized by less pronounced dilation of left cardiac chambers, relative preservation of left ventricular contractile function, more favorable course of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> with lower frequency of destabilizations of clinical state </plain></SENT>
<SENT sid="3" pm="."><plain>PCMP has developed mainly during postportal period and in women with preexisting <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001799'>viral</z:mp> diseases </plain></SENT>
</text></document>